Day 2Peripheral vascular diseaseStructural heart disease

SOLACI-SOCIME 2022 | Rol de los Dispositivos Fenestrados en Hipertensión Arterial Pulmonar, by Dr. Daniel Springmuller

solaci
solaci
485
0

Read the most outstanding articles from the second day of the SOLACI-SOCIME 2022 Congress.

In this case, consult the presentation by Dr. Daniel Springmuller, entitled “Rol de los Dispositivos Fenestrados en Hipertensión Arterial Pulmonar”

ago-5-springmuller-fenestrated-devices

Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Previous article
SOLACI-SOCIME 2022 | Pulsta Valve implantation : How do I do it?, by Dr. Alejandro Peirone
Next article
SOLACI-SOCIME 2022 | Reemplazo transcatéter de válvula pulmonar Experiencia con Melody y Harmony, by Dr. Alejandro Torres
solaci
solaci

More articles by this author

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

Dr. Juan Manuel Pérez - 0
The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

Dr. Omar Tupayachi - 0
The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...

Therapeutic strategies in carotid free-floating thrombus: evidence and controversies

Dr. Juan Manuel Pérez - 0
Carotid free-floating thrombus (cFFT) is a rare entity with a high embolic risk, associated with acute neurological events such as stroke or transient ischemic...

The Two Sides of the Coin: What Do CHAMPION-AF and CLOSURE-AF Teach Us About Left Atrial Appendage Closure?

Dr. Juan Manuel Pérez - 0
Letter to the editor: Juan Manuel Pérez Asorey Percutaneous left atrial appendage closure (LAAO) is currently going through one of the most interesting stages of...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

Structural heart disease

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the...
Dr. Juan Manuel Pérez -
SOLACI Sessionsspot_img

Recent Articles

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Dr. Andrés Rodríguez - 0
Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

Dr. Juan Manuel Pérez - 0
The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

Dr. Omar Tupayachi - 0
The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...